1. Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, et al. The prevalence of pituitary adenomas. Cancer. 2004;101(3):613-9. doi: https://doi.org/10.1002/cncr.20412.
2. Caimari F, Korbonits M. Novel Genetic Causes of Pituitary Adenomas. Clinical Cancer Research. 2016;22(20):5030-42. doi: 10.1158/1078-0432.ccr-16-0452.
3. Bi WL, Horowitz P, Greenwald NF, Abedalthagafi M, Agarwalla PK, Gibson WJ, et al. Landscape of Genomic Alterations in Pituitary Adenomas. Clinical Cancer Research. 2017;23(7):1841-51. doi: 10.1158/1078-0432.ccr-16-0790.
4. Song Z-J, Reitman ZJ, Ma Z-Y, Chen J-H, Zhang Q-L, Shou X-F, et al. The genome-wide mutational landscape of pituitary adenomas. Cell research. 2016;26(11):1255-9.
5. Sun J, Shen D, Gao Y, Zheng Y, Zhao L, Maa M, et al. Down-Regulation of USP8 Suppresses HER-3 Positive Gastric Cancer Cells Proliferation. OncoTargets and therapy. 2020;13:7973.
6. Jing X, Chen Y, Chen Y, Shi G, Lv S, Cheng N, et al. Down-regulation of USP8 Inhibits Cholangiocarcinoma Cell Proliferation and Invasion. Cancer Management and Research. 2020;12:2185.
7. Shin S, Kim K, Kim H-R, Ylaya K, Do S-I, Hewitt SM, et al. Deubiquitylation and stabilization of Notch1 intracellular domain by ubiquitin-specific protease 8 enhance tumorigenesis in breast cancer. Cell Death & Differentiation. 2020;27(4):1341-54.
8. Qiu H, Kong J, Cheng Y, Li G. The expression of ubiquitin‐specific peptidase 8 and its prognostic role in patients with breast cancer. Journal of Cellular Biochemistry. 2018;119(12):10051-8.
9. Yan M, Zhao C, Wei N, Wu X, Cui J, Xing Y. High expression of ubiquitin-specific protease 8 (USP8) is associated with poor prognosis in patients with cervical squamous cell carcinoma. Medical science monitor: international medical journal of experimental and clinical research. 2018;24:4934.
10. Hussain S, Zhang Y, Galardy P. DUBs and cancer: the role of deubiquitinating enzymes as oncogenes, non-oncogenes and tumor suppressors. Cell cycle. 2009;8(11):1688-97.
11. Byun S, Lee S-Y, Lee J, Jeong C-H, Farrand L, Lim S, et al. USP8 is a novel target for overcoming gefitinib resistance in lung cancer. Clinical cancer research. 2013;19(14):3894-904.
12. Kato M, Miyazawa K, Kitamura N. A deubiquitinating enzyme UBPY interacts with the Src homology 3 domain of Hrs-binding protein via a novel binding motif PX (V/I)(D/N) RXXKP. Journal of Biological Chemistry. 2000;275(48):37481-7.
13. Gnesutta N, Ceriani M, Innocenti M, Mauri I, Zippel R, Sturani E, et al. Cloning and characterization of mouse UBPy, a deubiquitinating enzyme that interacts with the Ras guanine nucleotide exchange factor CDC25Mm/Ras-GRF1. Journal of Biological Chemistry. 2001;276(42):39448-54.
14. Row PE, Prior IA, McCullough J, Clague MJ, Urbé S. The ubiquitin isopeptidase UBPY regulates endosomal ubiquitin dynamics and is essential for receptor down-regulation. Journal of Biological Chemistry. 2006;281(18):12618-24.
15. Mizuno E, Iura T, Mukai A, Yoshimori T, Kitamura N, Komada M. Regulation of epidermal growth factor receptor down-regulation by UBPY-mediated deubiquitination at endosomes. Molecular biology of the cell. 2005;16(11):5163-74.
16. Alwan HA, van Leeuwen JE. UBPY-mediated epidermal growth factor receptor (EGFR) de-ubiquitination promotes EGFR degradation. Journal of Biological Chemistry. 2007;282(3):1658-69.
17. Berruti G, Martegani E. Ubiquitin specific peptidase 8. 2013.
18. Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Tissue-based map of the human proteome. Science. 2015;347(6220).
19. : https://www.proteinatlas.org/ENSG00000138592-USP8 Accessed.
20. S.SrinivasanZ.Nawaz. 35 - Molecular Biology of Estrogen Receptor Action. In: Donald W. Pfaff APA, Anne M. Etgen, Susan E. Fahrbach, Robert T. Rubin, editor. Hormones, Brain and Behavior (Second Edition). Academic Press; 2009. p. 1187-220.
21. Kulathu Y, Komander D. Atypical ubiquitylation - the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages. Nature reviews Molecular cell biology. 2012;13(8):508-23. doi: 10.1038/nrm3394.
22. Reyes-Turcu FE, Ventii KH, Wilkinson KD. Regulation and Cellular Roles of Ubiquitin-Specific Deubiquitinating Enzymes. Annual Review of Biochemistry. 2009;78(1):363-97. doi: 10.1146/annurev.biochem.78.082307.091526.
23. Theodoropoulou M, Reincke M, Fassnacht M, Komada M. Decoding the genetic basis of Cushing's disease: USP8 in the spotlight. European journal of endocrinology. 2015;173(4):M73-83. doi: 10.1530/eje-15-0320.
24. Jing X, Chen Y, Chen Y, Shi G, Lv S, Cheng N, et al. Down-regulation of USP8 Inhibits Cholangiocarcinoma Cell Proliferation and Invasion. Cancer Manag Res. 2020;12:2185-94. doi: 10.2147/cmar.s234586.
25. Yan M, Zhao C, Wei N, Wu X, Cui J, Xing Y. High Expression of Ubiquitin-Specific Protease 8 (USP8) Is Associated with Poor Prognosis in Patients with Cervical Squamous Cell Carcinoma. Medical science monitor : international medical journal of experimental and clinical research. 2018;24:4934-43. doi: 10.12659/msm.909235.
26. Byun S, Lee SY, Lee J, Jeong CH, Farrand L, Lim S, et al. USP8 is a novel target for overcoming gefitinib resistance in lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2013;19(14):3894-904. doi: 10.1158/1078-0432.ccr-12-3696.
27. Reincke M, Sbiera S, Hayakawa A, Theodoropoulou M, Osswald A, Beuschlein F, et al. Mutations in the deubiquitinase gene USP8 cause Cushing's disease. Nature Genetics. 2015;47(1):31-8. doi: 10.1038/ng.3166.
28. Ma Z-Y, Song Z-J, Chen J-H, Wang Y-F, Li S-Q, Zhou L-F, et al. Recurrent gain-of-function USP8 mutations in Cushing's disease. Cell Research. 2015;25(3):306-17. doi: 10.1038/cr.2015.20.
29. Renner U, Pagotto U, Arzt E, Stalla GK. Autocrine and paracrine roles of polypeptide growth factors, cytokines and vasogenic substances in normal and tumorous pituitary function and growth: a review. European journal of endocrinology. 1996;135(5):515-32. doi: 10.1530/eje.0.1350515.